Corrections

Recent developments in secondary prevention and cardiac rehabilitation after acute myocardial infarction

BMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7445.926-a (Published 15 April 2004) Cite this as: BMJ 2004;328:926

As a result of technology problems, some amendments from the authors did not make it into this clinical review by Hasnain Dalal and colleagues (20 March, pp 693-7). In box 2, we should have added the website address for SEARCH (the study of additional reductions in cholesterol and homocysteine): www.ctsu.ox.ac.uk/projects/search.shtml. And the penultimate sentence of the subsection “Angiotensin converting enzyme inhibitors” should have said that rates of revascularisation (not rates of readmission for heart failure) were reduced in patients who took ramipril.

Footnotes

View Abstract